Ann: Neurology & Epilepsy Expert Joins MXC Medical Advisory Board, page-5

Break this down. Through epilepsy Australia mxc has 100 registered patients waiting for cannepil. That will generate $1 million dollars annually.
This doctor has 3 000 patients on their books. Let's say that we are able to get access to 10% of those. Fairly conservative number.
That would equate to 3 million dollars plus the other 1 million would equal four million a year for 2019. Not enough for a profit but a good start.
By my calculations if we could nab 20% then the company could turn a profit on cannepil alone.

This is why GMP was so important.